We elucidate here the mechanistic contribution of a novel electroconductive hydroxyapatite-20 wt.% titanium disilicide (HA–TiSi2) composite system in favorably modulating osteoblast functions in relation to the monolithic HA. The higher electrical conductivity of HA–TiSi2 (σDC ∼ 67.117 ± 3.57 S/m) in comparison to glass sample effectively guided the electroactive myoblast, leading to their significant alignment and proliferation. This favorable behavior is attributed to the formation of small electrochemical cells between HA and TiSi2 phase, which produce a small electric field, directing the electroactive myoblast to migrate and grow in a particular direction. In contrast, no impact of TiSi2 on osteoblast function was observed because of their inability to respond to small electric field. However, the in vitro bioactivity in simulated body fluid indicated the nucleation and growth of apatite crystals. Moreover, in the context of load-bearing capability, the presence of 20 wt.% TiSi2 in HA led to increase in the fracture toughness by ∼100%. This study underscores the effectiveness of HA–TiSi2 in favorably modulating the cellular activity, myoblast in particular.
ParkJBLakesRS. Biomaterials – an introduction, 2nd ed. New York and London: Plenum Press, 1992.
2.
BlackJ. Biological performance of materials-fundamentals of biocompatibility, New York: Marcel Dekker Inc., 1992.
3.
FukadaEYasudaI. On the piezoelectric effect of bone. J Physical Soc Jpn1957; 12: 1158–1162.
4.
IsaacsonBMBloebaumRD. Bone bioelectricity: what have we learned in the past 160 years?J Biomed Mater Res Part A2010; 95: 1270–1279.
5.
RyabyJT. Clinical effects of electromagnetic and electric fields on fracture healing. Clin Orthopaed Relate Res1998; 355: S205–S215.
6.
AndrewCBassettLPawlukRJ. Augmentation of bone repair by inductively coupled electromagnetic fields. Science1974; 184: 575–577.
7.
DarendelilerMADarendelilerASinclairPM. Effects of static magnetic and pulsed electromagnetic fields on bone healing. Int J Adult Orthodontics Orthognathic Surg1996; 12: 43–53.
8.
MengSRouabhiaMZhangZ. Electrical stimulation modulates osteoblast proliferation and bone protein production through heparin‐bioactivated conductive scaffolds. Bioelectromagnetics2013; 34: 189–199.
9.
WangZClarkCCBrightonCT. Up-regulation of bone morphogenetic proteins in cultured murine bone cells with use of specific electric fields. J Bone Joint Surg2006; 88: 1053–1065.
10.
KumarANuneKMisraRDK. Electric field-mediated growth of osteoblast-the significant impact of dynamic flow of medium. Biomater Sci2015.
11.
ShahiniAYazdimamaghaniMWalkerKJ. 3D conductive nanocomposite scaffold for bone tissue engineering. Int J Nanomed2014; 9: 167–167.
12.
BalintRCassidyNJCartmellSH. Conductive polymers: towards a smart biomaterial for tissue engineering. Acta Biomater2014; 10: 2341–2353.
13.
LakardBPlouxLAnselmeK. Effect of ultrasounds on the electrochemical synthesis of polypyrrole, application to the adhesion and growth of biological cells. Bioelectrochemistry2009; 75: 148–157.
14.
Ghasemi-MobarakehLPrabhakaranMPMorshedM. Application of conductive polymers, scaffolds and electrical stimulation for nerve tissue engineering. J Tissue Eng Regenerat Med2011; 5: e17–e35.
15.
HuangLZhuangXHuJ. Synthesis of biodegradable and electroactive multiblock polylactide and aniline pentamer copolymer for tissue engineering applications. Biomacromolecules2008; 9: 850–858.
16.
RiversTJHudsonTWSchmidtCE. Synthesis of a novel, biodegradable electrically conducting polymer for biomedical applications. Adv Function Mater2002; 12: 33–37.
17.
HardyJGVillancio-WolterMKSukhavasiRC. Electrical stimulation of human mesenchymal stem cells on conductive nanofibers enhances their differentiation toward osteogenic outcomes. Macromol Rapid Commun2015; 36: 1884–1890.
18.
ShiGZhangZRouabhiaM. The regulation of cell functions electrically using biodegradable polypyrrole–polylactide conductors. Biomaterials2008; 29: 3792–3798.
19.
XieJMacEwanMRWillerthSM. Conductive core-sheath nanofibers and their potential application in neural tissue engineering. Adv Function Mater2009; 19: 2312–2312.
20.
SupronowiczPRAjayanPMUllmannKR. Novel current‐conducting composite substrates for exposing osteoblasts to alternating current stimulation. J Biomed Mater Res2002; 59: 499–506.
21.
KusakabeHSakamakiTNiheiK. Osseointegration of a hydroxyapatite-coated multilayered mesh stem. Biomaterials2004; 25: 2957–2969.
22.
KumarAWebsterTJBiswasK. Flow cytometry analysis of human fetal osteoblast fate processes on spark plasma sintered hydroxyapatite–titanium biocomposites. J Biomed Mater Res Part A2013; 101: 2925–2938.
23.
KumarABhaskarNBasuB. Flow cytometry analysis of cytotoxicity in vitro and long‐term toxicity of HA‐40 wt% BaTiO3 nanoparticles in vivo. J Am Ceram Soc2015; 98: 3202–3211.
24.
AlokKKrishanuBBikramjitB. Fretting wear behaviour of hydroxyapatite–titanium composites in simulated body fluid, supplemented with 5 g l−1 bovine serum albumin. J Phys D: Appl Phys2013; 46: 404004–404004.
25.
KumarADharaSBiswasK. In vitro bioactivity and cytocompatibility properties of spark plasma sintered HA-Ti composites. J Biomed Mater Res B: Appl Biomater2013; 101B: 223–236.
26.
MuruganRRamakrishnaS. Development of nanocomposites for bone grafting. Compos Sci Technol2005; 65: 2385–2406.
27.
KongYMKimSKimHE. Reinforcement of hydroxyapatite bioceramic by addition of ZrO2 coated with Al2O3. J Am Ceram Soc1999; 82: 2963–2968.
28.
NathSBiswasKWangK. Sintering, phase stability, and properties of calcium phosphate‐mullite composites. J Am Ceram Soc2010; 93: 1639–1649.
29.
NathSKalmodiaSBasuB. Densification, phase stability and in vitro biocompatibility property of hydroxyapatite-10 wt% silver composites. J Mater Sci: Mater Med2010; 21: 1273–1287.
30.
KumarABiswasKBasuB. On the toughness enhancement in hydroxyapatite-based composites. Acta Materialia2013; 61: 5198–5215.
31.
BabushkinOLindbäckTHolmgrenA. Thermal expansion of hot isostatically pressed hydroxyapatite. J Mater Chem1994; 4: 413–415.
32.
LütjeringGWilliamsJC. Titanium, New York: Springer Berlin Heidelberg, 2007.
33.
SunJSTsuangYHYaoCH. Effects of calcium phosphate bioceramics on skeletal muscle cells. J Biomed Mater Res1997; 34: 227–233.
34.
StoutDAYooJSantiago-MirandaAN. Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular application. Int J Nanomed2012; 7: 5653–5653.
QaziTHRaiRBoccacciniAR. Tissue engineering of electrically responsive tissues using polyaniline based polymers: a review. Biomaterials2014; 35: 9068–9086.
37.
KumarABasuBMisraRDK. Structure–property relationship in an electroconductive hydroxyapatite-titanium disilicide composite. Int J Appl Ceram Technol2015.
38.
TagaiHAokiH. Preparation of synthetic hydroxyapatite and sintering of apatite ceramics, Chichester, England: John Wiley and Sons, 1980.
39.
KumarAMallikAKAcikbasNC. Cytocompatibility property evaluation of gas pressure sintered SiAlON–SiC composites with L929 fibroblast cells and Saos-2 osteoblast-like cells. Mater Sci Eng: C2012; 32: 464–469.
40.
OyaneAKimH-MFuruyaT. Preparation and assessment of revised simulated body fluids. Inc J Biomed Mater Res2003; 65A: 188–195.
41.
YukselNKanikAEBaykaraT. Comparision of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int J Pharmaceut2000; 209: 57–67.
42.
YeHLiuXYHongH. Characterization of sintered titanium/hydroxyapatite biocomposite using FTIR spectroscopy. J Mater Sci: Mater Med2009; 20: 843–850.
43.
AntonakosALiarokapisELeventouriT. Micro-Raman and FTIR studies of synthetic and natural apatites. Biomaterials2007; 28: 3043–3054.
44.
PossetULöcklinEThullR. Vibrational spectroscopic study of tetracalcium phosphate in pure polycrystalline form and as a constituent of a self-setting bone cement. J Biomed Mater Res1998; 40: 640–645.
45.
Rapacz-KmitaAPaluszkiewiczCŚlósarczykA. FTIR and XRD investigations on the thermal stability of hydroxyapatite during hot pressing and pressureless sintering processes. J Molecul Struct2005; 744–747: 653–656.
46.
NishikawaH. Thermal behavior of hydroxyapatite in structural and spectrophotometric characteristics. Mater Lett2001; 50: 364–370.
47.
RehmanIBonfieldW. Characterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy. J Mater Sci: Mater Med1997; 8: 1–4.
48.
SarginYKizilyalliMTelliC. A new method for the solid-state synthesis of tetracalcium phosphate, a dental cement: X-ray powder diffraction and IR studies. J Eur Ceram Soc1997; 17: 963–970.
49.
JalotaSTasACBhaduriSB. Synthesis of HA-Seeded TTCP (Ca4(PO4)2O) Powders at 1230℃ from Ca(CH3COO)2·H2O and NH4H2PO4. J Am Ceram Soc2005; 88: 3353–3360.
50.
RibeiroCCGibsonIBarbosaMA. The uptake of titanium ions by hydroxyapatite particles—structural changes and possible mechanisms. Biomaterials2006; 27: 1749–1761.
51.
FowlerBO. Infrared studies of apatites. I. Vibrational assignments for calcium, strontium, and barium hydroxyapatites utilizing isotopic substitution. Inorganic Chem1974; 13: 194–207.
52.
StutmanJMTermineJDPosnerAS. Vibrational spectra and structure of the phosphate ion in some calcium phosphates. Transact N Y Acad Sci1965; 27: 669–675.
53.
GadaletaSJPaschalisEPCamachoNP. Fourier transform infrared spectroscopy of synthetic and biological apatites, New York: Plenum Press, 1995.
54.
KleeWEEngelG. I.R. spectra of the phosphate ions in various apatites. J Inorganic Nucl Chem1970; 32: 1837–1843.
55.
BaddielCBBerryEE. Spectra structure correlations in hydroxy and fluorapatite. Spectrochim Acta1966; 22: 1407–1416.
56.
JorisSJAmbergCH. Nature of deficiency in nonstoichiometric hydroxyapatites. II. Spectroscopic studies of calcium and strontium hydroxyapatites. J Phys Chem1971; 75: 3172–3178.
57.
SahithiKSwethaMRamasamyK. Polymeric composites containing carbon nanotubes for bone tissue engineering. Int J Biol Macromol2010; 46: 281–283.
58.
JunIJeongSShinH. The stimulation of myoblast differentiation by electrically conductive sub-micron fibers. Biomaterials2009; 30: 2038–2047.
59.
ThrivikramanGMallikPKBasuB. Substrate conductivity dependent modulation of cell proliferation and differentiation in vitro. Biomaterials2013; 34: 7073–7085.
60.
LeontievaOVDemidenkoZNBlagosklonnyMV. Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program. Proc Natl Acad Sci2014; 111: 8832–8837.
